Lemaitre Vascular Inc (LMAT) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket
 
Lemaitre Vascular Inc   (NASDAQ: LMAT)

Select the Financial Report: Select the Period:


Description of Lemaitre Vascular Inc's Business Segments


Lemaitre Vascular Inc. is recognized as a leader in the field of vascular medicine, focusing on the development, manufacturing, and marketing of a comprehensive array of advanced medical devices aimed at addressing various vascular diseases. The company operates primarily in four key segments, each addressing specific aspects of vascular health, and it offers an extensive portfolio of both products and services.

Segments:

1. Endovascular Segment:
- This segment is dedicated to creating cutting-edge technologies for the endovascular market, which involves minimally invasive procedures using catheters and other devices to treat conditions affecting blood vessels.
- Key offerings include:
- Stents: Devices that are inserted into blood vessels to keep them open, facilitating blood flow.
- Catheters: Thin tubes that can be used to deliver medications or perform other interventions.
- Embolic Protection Devices: Instruments designed to prevent debris from traveling to the brain or other vital organs during vascular procedures.
- Wire Guides: Flexible wires that assist in navigating catheters and other devices through the vascular system.
- Introducer Sheaths: Devices used to gain access to blood vessels while minimizing trauma and facilitating the introduction of additional instruments.

2. Peripheral Segment:
- Focused on products that treat peripheral arterial disease (PAD), which can cause pain and disability due to reduced blood flow to the limbs.
- Notable products include:
- Iliac Stents: Devices specifically designed for the iliac arteries that supply blood to the pelvis and legs, improving blood flow to those areas.
- Femoropopliteal Stents: These are used in the superficial femoral artery, commonly addressing blockages caused by PAD.
- Embolic Protection Devices: Similar to those in the endovascular segment, but tailored for peripheral interventions.

3. Access Segment:
- An essential part of vascular procedures involves gaining access to the vascular system safely and effectively.
- Products include:
- Introducer Sheaths: These create a pathway for other instruments.
- Dilators: Tools that help expand openings in blood vessels to facilitate the insertion of other devices.
- Wire Guides: Assisting in directional guidance within the vascular system.

4. OEM Segment:
- This segment focuses on providing original equipment manufacturing services. Lemaitre Vascular collaborates with other medical device companies to assist in the production of specialized vascular tools and implants, leveraging its expertise and resources in design and manufacturing.

Products:

1. Auryon:
- A state-of-the-art laser technology system designed to remove plaque, which obstructs blood vessels precipitating PAD. It allows for precise targeting and minimally invasive interventions.

2. VascuSeal:
- A novel sealant technology that effectively seals arteriotomies, or surgical openings created in blood vessels during endovascular procedures, enhancing patient recovery and minimizing potential complications related to bleeding.

3. XenoSure:
- Utilized for reinforcing connections made during vascular surgeries, particularly those involving expanded polytetrafluoroethylene (ePTFE) grafts, ensuring durability and strength at the junction with the patients vascular tissue.

4. LeMaitre Stent Graft:
- A specialized device employed for the endovascular repair of abdominal aortic aneurysms, offering a less invasive alternative to traditional open surgical techniques, therefore reducing recovery time and risk of complications.

Services:

1. Educational Programs:
- Lemaitre Vascular actively provides comprehensive training to healthcare practitioners through workshops, seminars, and resources that educate them on the effective use of their products and keep them abreast of the latest advancements in vascular medicine.

2. Clinical Support and Training:
- The company offers robust support systems for healthcare professionals, including case analyses and hands-on training in selected medical facilities. This service enhances competency in utilizing their medical devices and improves patient outcomes.

3. Technical Support:
- Expert technical assistance is available for medical professionals requiring guidance on the application and effective use of Lemaitre Vasculars devices. This support is crucial in ensuring optimal integration of their technologies in clinical settings.

Conclusion:

Lemaitre Vascular Inc. stands out for its commitment to innovation and high-quality vascular treatment options, offering an extensive range of products and services that facilitate the diagnosis, treatment, and management of vascular diseases. Their dedication to supporting healthcare professionals ensures that they remain at the forefront of vascular care, leading to improved patient outcomes and advancements in the field of vascular medicine.


Composition of Lemaitre Vascular Inc Revenues by Segments

 
United States    56.01 % of total Revenue
Germany    8.34 % of total Revenue
Canada    6.1 % of total Revenue
United Kingdom    4.71 % of total Revenue
Other countries    25.07 % of total Revenue

Q1 three months ended (Mar 31 2026)
Revenues by Business Segments Revenues
(in millions $)
%
(of total Revenues)
United States 37.19 56.01 %
Germany 5.54 8.34 %
Canada 4.05 6.1 %
United Kingdom 3.13 4.71 %
Other countries 16.65 25.07 %
Total 66.40 100 %




Q1 three months ended (Mar 31 2026)
Revenue Growth rates by Segment Y/Y Revenue
%
Q/Q Revenue
%
United States - -
Germany - -
Canada - -
United Kingdom - -
Other countries - -
Total 11.74 % -73.39 %




Q1 three months ended (Mar 31 2026)
Income by Business Segments Income
(in millions $)
%
(Profit Margin)
Total 15.68 23.61 %




Q1 three months ended (Mar 31 2026)
Income Growth rates by Segment Y/Y Income
%
Q/Q Income
%
Total 42.39 % -72.84 %




Annual Report on Lemaitre Vascular Inc Divisions, Sales by Country

 
United States   United States Segment contribution to total sales 56.73 % of total Revenue
Germany   Germany Segment contribution to total sales 7.17 % of total Revenue
Canada   Canada Segment contribution to total sales 6.11 % of total Revenue
United Kingdom   United Kingdom Segment contribution to total sales 5.3 % of total Revenue
Other countries   Other countries Segment contribution to total sales 24.71 % of total Revenue
Americas   Americas Segment contribution to total sales 63.98 % of total Revenue
EMEA   EMEA Segment contribution to total sales 29.3 % of total Revenue
Asia Pacific   Asia Pacific Segment contribution to total sales 6.74 % of total Revenue


Twelve months ended 2025
LMAT s Annual Revenue by Geography and Business Segments Sales
(in millions $)
%
(of total Sales)
United States 141.57 56.73 %
Germany 17.90 7.17 %
Canada 15.25 6.11 %
United Kingdom 13.22 5.3 %
Other countries 61.67 24.71 %
Total 249.54 100 %
Americas 159.67 63.98 %
EMEA 73.12 29.3 %
Asia Pacific 16.82 6.74 %


Twelve months ended 2025
LMAT s Annual Income by Country and Business Segments Income
(in millions $)
%
(Profit Margin)
Total 57.73 23.14 %

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
Total 14 % 31.1 %
UNITED STATES - -
GERMANY - -
CANADA - -
UNITED KINGDOM - -
Other Countries - -
Americas 10.43 % -
EMEA 21.93 % -
Asia Pacific 9.82 % -



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.